[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487770":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":28,"responsibleParty":58,"collaborators":11,"id":62,"slug":11,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":11,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":11,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":30,"whyStopped":11,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR",null,[13],"Drug: Placebo",{"label":15,"type":16,"description":11,"interventionNames":17},"Intervention","EXPERIMENTAL",[18],"Drug: Dexamethasone",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","Dexamethasone","Patients treated with dexamethasone",[15],{"type":21,"name":9,"description":26,"armGroupLabels":27,"otherNames":11},"Patients treated with placebo",[9],[29,47],{"facility":5,"status":30,"city":31,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Bangkok","Thailand","TH",{"type":35,"coordinates":36},"Point",[37,38],100.50144,13.75398,{"lat":38,"lon":37},[41],{"name":42,"role":43,"phone":44,"phoneExt":45,"email":46},"Nattachai Srisawat","CONTACT","02-256-4000","3597","drnattachai@yahoo.com",{"facility":48,"status":30,"city":31,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":49,"geoPoint":51,"contacts":52},"King Chulalongkorn Memorial Hospital",{"type":35,"coordinates":50},[37,38],{"lat":38,"lon":37},[53],{"name":54,"role":43,"phone":55,"phoneExt":56,"email":57},"Sasipha Tachaboon","6622564000","3679","sasipha_tac@hotmail.com",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Nattachai Srisawat ,M.D.","Principal investigator","100487770",false,"NCT05631405","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone","Inclusion Criteria:\n\n* Laboratory confirmed Dengue infected patients (Positive NS1 Ag or anti-DENV IgM by Dengue Duo test)\n* And still in febrile phase (Body temp\\>37.5 C)\n* Shock : Sys\\\u003C90mmHg or Narrow PP (\\\u003C20mmHg) orTachycardia (pulse\\>100\u002Fmin) with Hematocrit decreased ≥20 %\n* Fluid accumulation and respiratory distress\n* Severe bleeding\n* Severe organ involvement\n\nExclusion Criteria:\n\n* Severe dengue\\> 24 hrs\n* Dengue without warning signs\n* Pregnancy\n* Patient who receieved any steroid within 1 week","ALL","7 Years","99 Years",{"count":72,"type":73},200,"ESTIMATED","INTERVENTIONAL",[76],"NA","The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.",[79],"Severe Dengue",[79,22,81],"Steroid","2026-06-15",{"date":84,"type":85},"2026-06-16","ACTUAL",{"date":87,"type":85},"2022-10-16",{"date":89,"type":73},"2027-12-31",{"name":5,"class":6},2]